Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients

Archives of Oral Biology

Volumn 52, Issue 11, 2007, Pages 1079-1087

  Zhong, Lai ping ^a   Zhang, Chen ping ^a   Zheng, Jia wei ^a   Li, Jiang ^b   Chen, Wan tao ^a   Zhang, Zhi yuan ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b Ninth people's Hospital of Xi'an   (China)

Author keywords

Cyfra 21 1; Cytokeratin 19; Oral squamous cell carcinoma; Saliva

Indexed keywords

ANTIGEN CYFRA21.1; CYTOKERATIN 19; KERATIN; MESSENGER RNA; TUMOR ANTIGEN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METHODOLOGY; MIDDLE AGED; MORTALITY; MOUTH TUMOR; NONPARAMETRIC TEST; PATHOLOGY; PRECANCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ROC CURVE; SALIVA; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-19; KERATINS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; ROC CURVE; SALIVA; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 34848886852     PISSN: 00039969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archoralbio.2007.05.005     Document Type: Article

References (43)

1. De Vicente J.C., Recio O.R., Pendas S.L., Pendas S.L., and Lopez-Arranz J.S. Oral squamous cell carcinoma of the mandibular region: a survival study. Head Neck 23 (2001) 536-543
2. Neville B.W., and Day T.A. Oral cancer and precancerous lesions. CA Cancer J Clin 52 (2002) 195-215
3. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
4. Kurokawa H., Yamashita Y., Tokudome S., and Kajiyama M. Combination assay for tumor markers in oral squamous cell carcinoma. J Oral Maxillofac Surg 55 (1997) 964-966
5. Hoffmann J., Munz A., Krimmel M., and Alfter G. Intraoperative and postoperative kinetics of serum tumor markers in patients with oral carcinoma. J Oral Maxillofac Surg 56 (1998) 1390-1393
6. Rosati G., Riccardi F., and Tucci A. Use of tumor markers in the management of head and neck cancer. Int J Biol Markers 15 (2000) 179-183
7. Nagler R.M., Barak M., Peled M., Ben-Aryeh H., Filatov M., and Laufer D. Early diagnosis and treatment monitoring roles of tumor markers Cyfra 21-1 and TPS in oral squamous cell carcinoma. Cancer 85 (1999) 1018-1025
8. Zhong L.P., Zhu H.G., Zhang C.P., Chen W.T., and Zhang Z.Y. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma. Int J Oral Maxillofac Surg 36 (2007) 230-234
9. Cheng B., Rhodus N.L., Williams B., and Griffin R.J. Detection of apoptotic cells in whole saliva of patients with oral premalignant and malignant lesions: a preliminary study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 (2004) 465-470
10. Wong D.T. Salivary diagnostics powered by nanotechnologies, proteomics and genomics. J Am Dent Assoc 137 (2006) 313-321
11. Park N.J., Zhou X., Yu T., Brinkman B.M., Zimmermann B.G., Palanisamy V., et al. Characterization of salivary RNA by cDNA library analysis. Arch Oral Biol 52 (2007) 30-35
12. Zerah M., Pang S.Y., and New M.I. Morning salivary 17-hydroxyprogesterone is a useful screening test for nonclassical 21-hydroxylase deficiency. J Clin Endocrinol Metab 65 (1987) 227-232
13. Malamud D. Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. Am J Med 102 (1997) 9-14
14. Emmons W. Accuracy of oral specimen testing for human immunodeficiency virus. Am J Med 102 (1997) 15-20
15. Cameron S.O., Wilson K.S., Good T., McMenamin J., McCarron B., Pithie A., et al. Detection of antibodies against hepatitis C virus in saliva: a marker of viral replication. J Viral Hepat 6 (1999) 141-144
16. Zhevachevsky N.G., Nomokonova N.Y., Beklemishev A.B., and Belov G.F. Dynamic study of HbsAg and HBeAg in saliva samples from patients with hepatitis B infection: diagnostic and epidemiological significance. J Med Virol 61 (2000) 433-438
17. Streckfus C., Bigler L., Navazesh M., and Al-Hashimi I. Cytokine concentrations in stimulated whole saliva among patients with primary Sjogren's syndrome, secondary Sjogren's syndrome, and patients with primary Sjogren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: a preliminary study. Clin Oral Investig 5 (2001) 133-135
18. Aps J.K., Delanghe J., and Martens L.C. Salivary electrolyte concentrations are associated with cystic fibrosis transmembrane regulator genotypes. Clin Chem Lab Med 40 (2002) 345-350
19. Streckfus C.F., and Bigler L.R. Saliva as a diagnostic fluid. Oral Dis 8 (2002) 69-76
20. Bosch J.A., Turkenburg M., Nazmi K., Veerman E.C., de Geus E.J., and Amerongen A.V. Stress as a determinant of saliva mediated adherence and coadherence of oral and nonoral microorganisms. Psychosom Med 65 (2003) 604-612
21. Asatsuma M., Ito S., Watanabe M., Takeishi H., Nomura S., Wada Y., et al. Increase in the ratio of matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 in saliva from patients with primary Sjogren's syndrome. Clin Chim Acta 345 (2004) 99-104
22. Choo R.E., and Huestis M.A. Oral fluid as a diagnostic tool. Clin Chem Lab Med 42 (2004) 1273-1287
23. Boyle J.O., Mao L., Brennan J.A., Koch W.M., Eisele D.W., Saunders J.R., et al. Gene mutations in saliva as molecular markers for head and neck squamous cell carcinomas. Am J Surg 168 (1994) 429-432
24. Califano J., Ahrendt S.A., Meininger G., Westra W.H., Koch W.M., and Sidransky D. Detection of telomerase activity in oral rinses from head and neck squamous cell carcinoma patients. Cancer Res 56 (1996) 5720-5722
25. Liao P.H., Chang Y.C., Huang M.F., Tai K.W., and Chou M.Y. Mutation of p53 gene codon 63 in saliva as a molecular marker for oral squamous cell carcinomas. Oral Oncol 36 (2000) 272-276
26. 6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res 61 (2001) 939-942
27. Warnakulasuriya S., Soussi T., Maher R., Johnson N., and Tavassoli M. Expression of p53 in oral squamous cell carcinoma is associated with the presence of IgG and IgA p53 autoantibodies in sera and saliva of the patients. J Pathol 192 (2000) 52-57
28. Spafford M.F., Koch W.M., Reed A.L., Califano J.A., Xu L.H., Eisenberger C.F., et al. Detection of head and neck squamous cell carcinoma among exfoliated oral mucosal cells by microsatellite analysis. Clin Cancer Res 7 (2001) 607-612
29. Li Y., St John M.A., Zhou X., Kim Y., Sinha U., Jordan R.C., et al. Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10 (2004) 8442-8450
30. Zhong L.P., Chen G.F., Xu Z.F., Zhang X., Ping F.Y., and Zhao S.F. Detection of telomerase activity in saliva from oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg 34 (2005) 566-570
31. Pujol J.L., Grenier J., Daures J.P., Daver A., Pujol H., and Michel F.B. Serum fragment of cytokeratin subunit 19 measured by Cyfra 21-1 immunoradiometric assay as a marker of lung cancer. Cancer Res 53 (1993) 61-66
32. Yamamoto K., Oka M., Hayashi H., Tangoku A., Gondo T., and Suzuki T. CYFRA 21-1 is a useful marker for esophageal squamous cell carcinoma. Cancer 79 (1997) 1647-1655
33. Dohmoto K., Hojo S., Fujita J., Yang Y., Ueda Y., Bandoh S., et al. The role of caspase 3 in producing cytokeratin 19 fragment (CYFRA 21-1) in human lung cancer cell lines. Int J Cancer 91 (2001) 468-473
34. Sheard M.A., Vojtesek B., Simickova M., and Valik D. Release of cytokeratin-18 and -19 fragments (TPS and CYFRA 21-1) into the extracellular space during apoptosis. J Cell Biochem 85 (2002) 670-677
35. Sobin L.H., and Wittekind C.H. International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 5th Edition (1997), Wiley-Liss Inc., New York pp. 20-24
36. Barnes L., Eveson J.W., Reichart P., and Sidransky D. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours (2005), IARC Press, Lyon pp. 168-175
37. Zhong L.P., Zhao S.F., Chen G.F., Ping F.Y., Xu Z.F., and Hu J.A. Increased levels of CK19 mRNA in oral squamous cell carcinoma tissue detected by relative quantification with real-time polymerase chain reaction. Arch Oral Biol 51 (2006) 1112-1119
38. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)) method. Methods 25 (2001) 402-408
39. Lindberg K., and Rheinwald J.G. Suprabasal 40kd keratin (K19) expression as an immunohistologic marker of premalignancy in oral epithelium. Am J Pathol 134 (1989) 89-98
40. Su L., Morgan P.R., and Lane E.B. Keratin 14 and 19 expression in normal, dysplastic and malignant oral epithelia. A study using in situ hybridization and immunohistochemistry. J Oral Pathol Med 25 (1996) 293-301
41. Hamakawa H., Bao Y., Takarada M., Fukuzumi M., and Tanioka H. Cytokeratin expression in squamous cell carcinoma of the lung and oral cavity: an immunohistochemical study with possible clinical relevance. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85 (1998) 438-443
42. Nie M.H., Zhong L., Zeng G.M., and Li B.Q. The changes of cytokeratin 19 during oral carcinogenesis. Chin J Stomatol 37 (2002) 187-191 (in Chinese)
43. Vora H.H., Shah N.G., Patel D.D., Trivedi T.I., and Chikhlikar P.R. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis. J Surg Oncol 82 (2003) 34-50